Implications of Green Tea and Its Constituents in the Prevention of Cancer Via the Modulation of Cell Signalling Pathway

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2015 May 16

PMID 25977926

Citations 38

Authors

Arshad H Rahmani

Fahad M Al Shabrmi

Khaled S Allemailem

Salah M Aly

Masood A Khan

Affiliations

Soon will be listed here.

Abstract

Green tea is commonly used as a beverage worldwide, especially in China, Japan, Morocco, and Saudi Arabia. Green tea and its constituents have been considered very effective in the prevention and treatment of various diseases. It contains a variety of catechins, which show a pivotal role in the modulation of biological activities and also act as chemopreventive agents. Earlier studies have confirmed that green tea and its chief constituent epigallocatechin gallate (EGCG) have a potential role in the management of cancer through the modulation of cell signaling pathways. In this review, we focused on the beneficial effects of green tea and its constituents in the cancer prevention and treatment and its impact on modulation of molecular pathways.

Citing Articles

Green Tea: Current Knowledge and Issues.

Radeva-Ilieva M, Stoeva S, Hvarchanova N, Georgiev K Foods. 2025; 14(5).

PMID: 40077449 PMC: 11899301. DOI: 10.3390/foods14050745.

Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential.

Capasso L, De Masi L, Sirignano C, Maresca V, Basile A, Nebbioso A Molecules. 2025; 30(3).

PMID: 39942757 PMC: 11821029. DOI: 10.3390/molecules30030654.

QM-CSA: A Novel Quantum Mechanics-Based Protocol for Evaluation of the Carcinogen-Scavenging Activity of Polyphenolic Compounds.

Furlan V, Tosovic J, Bren U Foods. 2024; 13(17).

PMID: 39272474 PMC: 11394233. DOI: 10.3390/foods13172708.

From desert flora to cancer therapy: systematic exploration of multi-pathway mechanisms using network pharmacology and molecular modeling approaches.

Alblihy A Front Pharmacol. 2024; 15:1345415.

PMID: 38666020 PMC: 11043532. DOI: 10.3389/fphar.2024.1345415.

Potential Benefits of Green Tea in Prostate Cancer Prevention and Treatment: A Comprehensive Review.

Liu G, Yao Z, Chen G, Li Y, Liang B Chin J Integr Med. 2024; 30(11):1045-1055.

PMID: 38561489 DOI: 10.1007/s11655-024-4100-2.

References

Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, Araki H . Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev. 2008; 17(11):3020-5. DOI: 10.1158/1055-9965.EPI-08-0528. View

Hastak K, Gupta S, Ahmad N, Agarwal M, Agarwal M, Mukhtar H . Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene. 2003; 22(31):4851-9. DOI: 10.1038/sj.onc.1206708. View

Isbrucker R, Edwards J, Wolz E, Davidovich A, Bausch J . Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol. 2006; 44(5):636-50. DOI: 10.1016/j.fct.2005.11.003. View

Rahmani A, Al Shabrmi F, Aly S . Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities. Int J Physiol Pathophysiol Pharmacol. 2014; 6(2):125-36. PMC: 4106649. View

Khan N, Mukhtar H . Tea polyphenols for health promotion. Life Sci. 2007; 81(7):519-33. PMC: 3220617. DOI: 10.1016/j.lfs.2007.06.011. View

Dufresne C, Farnworth E . A review of latest research findings on the health promotion properties of tea. J Nutr Biochem. 2001; 12(7):404-421. DOI: 10.1016/s0955-2863(01)00155-3. View

Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A . Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006; 66(2):1234-40. DOI: 10.1158/0008-5472.CAN-05-1145. View

Gu J, Makey K, Tucker K, Chinchar E, Mao X, Pei I . EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression. Vasc Cell. 2013; 5(1):9. PMC: 3649947. DOI: 10.1186/2045-824X-5-9. View

Jatoi A, Ellison N, Burch P, Sloan J, Dakhil S, Novotny P . A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer. 2003; 97(6):1442-6. DOI: 10.1002/cncr.11200. View

10.

Ahmad A, Husain A, Mujeeb M, Khan S, Najmi A, Siddique N . A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed. 2013; 3(5):337-52. PMC: 3642442. DOI: 10.1016/S2221-1691(13)60075-1. View

11.

Shimizu M, Deguchi A, Joe A, Mckoy J, Moriwaki H, Weinstein I . EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol. 2006; 5(1):69-78. View

12.

Lambert J, Kennett M, Sang S, Reuhl K, Ju J, Yang C . Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol. 2009; 48(1):409-16. PMC: 2905152. DOI: 10.1016/j.fct.2009.10.030. View

13.

Manach C, Williamson G, Morand C, Scalbert A, Remesy C . Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005; 81(1 Suppl):230S-242S. DOI: 10.1093/ajcn/81.1.230S. View

14.

Sadava D, Whitlock E, Kane S . The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem Biophys Res Commun. 2007; 360(1):233-7. DOI: 10.1016/j.bbrc.2007.06.030. View

15.

Yokoyama M, Noguchi M, Nakao Y, Pater A, Iwasaka T . The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines. Gynecol Oncol. 2004; 92(1):197-204. DOI: 10.1016/j.ygyno.2003.09.023. View

16.

Yang C, Wang Z . Tea and cancer. J Natl Cancer Inst. 1993; 85(13):1038-49. DOI: 10.1093/jnci/85.13.1038. View

17.

Liang Y, Lin-Shiau S, Chen C, Lin J . Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J Cell Biochem. 1999; 75(1):1-12. View

18.

Siddiqui I, Asim M, Hafeez B, Adhami V, Tarapore R, Mukhtar H . Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J. 2010; 25(4):1198-207. PMC: 3058706. DOI: 10.1096/fj.10-167924. View

19.

Yang F, de Villiers W, McClain C, Varilek G . Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr. 1998; 128(12):2334-40. DOI: 10.1093/jn/128.12.2334. View

20.

Navarro-Peran E, Cabezas-Herrera J, Campo L, Rodriguez-Lopez J . Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate. Int J Biochem Cell Biol. 2007; 39(12):2215-25. DOI: 10.1016/j.biocel.2007.06.005. View